Mark Howard Snyder - 20 Feb 2026 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
20 Feb 2026
Net transactions value
-$471,299
Form type
4
Filing time
24 Feb 2026, 18:16:08 UTC
Previous filing
17 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 24 Feb 2026 0001902866

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +5,332 +13% $0.000000 47,257 20 Feb 2026 Direct
transaction HALO Common Stock Tax liability $204,138 -2,876 -6.1% $70.98 44,381 20 Feb 2026 Direct F1
transaction HALO Common Stock Options Exercise $0 +7,011 +16% $0.000000 51,392 23 Feb 2026 Direct
transaction HALO Common Stock Tax liability $267,160 -3,782 -7.4% $70.64 47,610 23 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -5,332 -25% $0.000000 15,995 20 Feb 2026 Common Stock 5,332 $0.000000 Direct F3
transaction HALO Restricted Stock Units Options Exercise $0 -7,011 -33% $0.000000 14,022 23 Feb 2026 Common Stock 7,011 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,876 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 3,782 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.